CN1206240C - High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology - Google Patents
High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology Download PDFInfo
- Publication number
- CN1206240C CN1206240C CN 03109189 CN03109189A CN1206240C CN 1206240 C CN1206240 C CN 1206240C CN 03109189 CN03109189 CN 03109189 CN 03109189 A CN03109189 A CN 03109189A CN 1206240 C CN1206240 C CN 1206240C
- Authority
- CN
- China
- Prior art keywords
- exchange membrane
- vitellogenin
- technology
- vitelloenin
- decontamination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000005516 engineering process Methods 0.000 title claims abstract description 7
- 238000011140 membrane chromatography Methods 0.000 title abstract description 3
- 238000005202 decontamination Methods 0.000 title 1
- 230000003588 decontaminative effect Effects 0.000 title 1
- 108010090932 Vitellogenins Proteins 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 239000003011 anion exchange membrane Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 210000004369 blood Anatomy 0.000 claims abstract description 7
- 239000008280 blood Substances 0.000 claims abstract description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000012723 sample buffer Substances 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- CJKRXEBLWJVYJD-UHFFFAOYSA-N N,N'-diethylethylenediamine Chemical compound CCNCCNCC CJKRXEBLWJVYJD-UHFFFAOYSA-N 0.000 claims description 2
- 238000010828 elution Methods 0.000 claims description 2
- 125000000524 functional group Chemical group 0.000 claims description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 238000000746 purification Methods 0.000 abstract description 4
- 239000002904 solvent Substances 0.000 abstract description 3
- 239000003014 ion exchange membrane Substances 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 239000013543 active substance Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 241001609213 Carassius carassius Species 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 1
- 108010017596 Vitellins Proteins 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 231100000049 endocrine disruptor Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000613 environmental toxicology Toxicity 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000013017 sartobind Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明属于制备具有生物活性物质的工艺,涉及一种利用高效阴离子交换膜色谱方法从卵生动物的血液、或全身匀浆液中提取、纯化卵黄蛋白原的技术。本技术可在离子交换膜上实现蛋白质的快速浓缩与纯化,产品纯度高,回收率高。本发明可大大节省时间和溶剂用量,并且仪器设备简单,成本低廉。The invention belongs to a process for preparing biologically active substances, and relates to a technique for extracting and purifying vitellogenin from the blood or whole body homogenate of oviparous animals by using high-efficiency anion-exchange membrane chromatography. This technology can realize the fast concentration and purification of protein on the ion exchange membrane, and the product has high purity and high recovery rate. The invention can greatly save time and solvent consumption, and has simple equipment and low cost.
Description
发明领域field of invention
本发明属于蛋白质的制备领域,涉及一种利用高效阴离子交换膜色谱技术从卵生动物的血液、或全身匀浆液中提取、纯化卵黄蛋白原的技术。本技术可在离子交换膜上实现蛋白质的快速浓缩与纯化。本发明可大大节省时间和溶剂用量,并且仪器设备简单,成本低廉。The invention belongs to the field of protein preparation, and relates to a technology for extracting and purifying vitellogenin from the blood or whole body homogenate of oviparous animals by using high-efficiency anion-exchange membrane chromatography technology. This technology enables the rapid concentration and purification of proteins on ion-exchange membranes. The invention can greatly save time and solvent consumption, and has simple equipment and low cost.
背景技术Background technique
本技术领域的背景和发展现状大致如下:卵黄蛋白原是一种由雌激素诱导生成的高磷糖蛋白,是卵生动物卵黄蛋白的主要前体。正常情况下,雄性动物体内没有卵黄蛋白原,但是在雌激素或类雌激素的诱导下,雄性动物的肝脏也可合成卵黄蛋白原。所以,卵黄蛋白原被认为是一种理想的雌激素和类雌激素生物标志物,近年来被广泛用于环境内分泌干扰物的筛选及环境毒理、污染调查等研究之中。为适应对卵黄蛋白原进行快速和灵敏检测的要求,目前,已有多家公司已经或正在开发卵黄蛋白原的免疫检测试剂盒。在卵黄蛋白原免疫检测试剂盒的开发中,需要大量的纯化的卵黄蛋白原以免疫动物制备抗体,并且作为样品检测时的标准参比。传统的卵黄蛋白原纯化方法主要有离子交换柱色谱法、凝胶过滤色谱法、超速离心法、选择性沉淀法等,这些方法一般需要比较长的分离时间,并且溶液用量比较大。目前,类似本发明的卵黄蛋白原纯化方法尚未见报道。The background and development status of this technical field are roughly as follows: Vitellogenin is a high-phosphorus glycoprotein induced by estrogen and is the main precursor of vitellin in oviparous animals. Under normal circumstances, there is no vitellogenin in male animals, but under the induction of estrogen or estrogen, the liver of male animals can also synthesize vitellogenin. Therefore, vitellogenin is considered as an ideal estrogen and estrogen-like biomarker, and has been widely used in the screening of environmental endocrine disruptors, environmental toxicology, and pollution investigations in recent years. In order to meet the requirements of rapid and sensitive detection of vitellogenin, many companies have developed or are developing immunoassay kits for vitellogenin. In the development of vitellogenin immunoassay kits, a large amount of purified vitellogenin is needed to immunize animals to prepare antibodies, and it is used as a standard reference for sample detection. Traditional vitellogenin purification methods mainly include ion-exchange column chromatography, gel filtration chromatography, ultracentrifugation, selective precipitation, etc. These methods generally require a relatively long separation time and a large amount of solution is used. At present, the method for purifying vitellogenin similar to the present invention has not been reported yet.
有关这方面的文献可参见:Literature on this subject can be found at:
1.H.S.Wiley,L.Opresko,R.A.Wallace,Anal.Biochem.,97(1979)145-152.1. H.S. Wiley, L. Opresko, R.A. Wallace, Anal. Biochem., 97(1979) 145-152.
2.L.G.Parks,A.O.Cheek,N.D.Denslow,S.A.Heppell,J.A.McLachlan,G.A.LeBlanc,C.V.Sullivan,Comp.Biochem.Physiol.C,123(1999)113-125.2. L.G. Parks, A.O. Cheek, N.D. Denslow, S.A. Heppell, J.A. McLachlan, G.A. LeBlanc, C.V. Sullivan, Comp. Biochem. Physiol. C, 123 (1999) 113-125.
3.M.R.Redshaw,B.K.Follet,Biochem.J.,124(1971)759-766.3. M.R. Redshaw, B.K. Follet, Biochem. J., 124 (1971) 759-766.
4.F.Brion,F.Rogerieux,P.Noury,B.Migeon,P.Flammarion,E.Thybaud,J.M.Porcher,J.Chromatogr.B.,737(2000)3-12.4. F. Brion, F. Rogerieux, P. Noury, B. Migeon, P. Flammarion, E. Thybaud, J. M. Porcher, J. Chromatogr. B., 737 (2000) 3-12.
发明内容Contents of the invention
本发明的目的是提供一种可从卵生动物的血液、或全身匀浆液中快速分离纯化卵黄蛋白原的技术。The purpose of the present invention is to provide a technology for rapidly separating and purifying vitellogenin from the blood or whole body homogenate of oviparous animals.
完成本发明的技术方案是通过下述方式实现的。首先,选取健康的实验动物,以1-5μg/g的剂量腹腔注射17β-雌二醇,实验室饲养14-21天后,静脉取血,对个体非常小的动物直接进行全身匀浆。动物血液在4℃,3000转/分钟下离心20分钟后,取血清,按1∶5-10的比例用样品缓冲液(pH=6.5-8.5的磷酸盐或Tris-盐酸缓冲液,浓度为0.02mol/L,含NaCl 0.07mol/L)稀释,过0.45微米滤膜备用;动物匀浆液转移入离心管中,在4℃,10000转/分钟下离心30分钟,小心去除上层脂肪,将清液用0.45微米滤膜过滤,备用。纯化时,用10毫升样品缓冲液以10毫升/分钟的流速通过高效阴离子交换膜(SartobindTM MA15 Q,购自Sartorius公司,德国),使之预平衡,然后以10毫升/分钟的流速使样品溶液通过高效阴离子交换膜,并用10毫升样品缓冲液冲洗,以除去未结合的蛋白。接下来,分别用5毫升洗脱缓冲液A和B(pH=6.5-8.5的磷酸盐或Tris-盐酸缓冲液,浓度为0.02mol/L,含NaCl分别为0.27mol/L和0.42mol/L)依次冲洗阴离子交换膜,收集洗脱缓冲液B所对应的洗脱组份,此组份即为纯化的卵黄蛋白原。最后,用10毫升恢复缓冲液(pH=6.5-8.5的磷酸盐或Tris-盐酸缓冲液,浓度为0.02mol/L,含NaCl 1mol/L)冲洗高效阴离子交换膜,即可用于下一次分离。The technical solution for completing the present invention is achieved in the following manner. First, healthy experimental animals were selected and injected intraperitoneally with 17β-estradiol at a dose of 1-5 μg/g. After 14-21 days of laboratory feeding, blood was collected from a vein, and whole-body homogenization was directly performed on very small animals. Animal blood was centrifuged at 4°C and 3000 rpm for 20 minutes, and the serum was taken, and the sample buffer solution (phosphate or Tris-hydrochloric acid buffer solution with a pH of 6.5-8.5 at a concentration of 0.02 mol/L, containing NaCl 0.07mol/L), pass through a 0.45 micron filter membrane for later use; transfer the animal homogenate into a centrifuge tube, centrifuge at 4°C, 10,000 rpm for 30 minutes, carefully remove the upper layer of fat, and remove the supernatant Filter through a 0.45 micron membrane filter and set aside. During purification, use 10 milliliters of sample buffer to pass through a high-efficiency anion exchange membrane (Sartobind TM MA15 Q, purchased from Sartorius Company, Germany) at a flow rate of 10 ml/min to make it pre-equilibrated, and then make the sample The solution was passed through a high-efficiency anion-exchange membrane and washed with 10 mL of sample buffer to remove unbound protein. Next, use 5 milliliters of elution buffers A and B (phosphate or Tris-hydrochloric acid buffer solution at pH=6.5-8.5, the concentration is 0.02mol/L, containing 0.27mol/L and 0.42mol/L NaCl respectively ) successively wash the anion exchange membrane, and collect the elution fraction corresponding to the elution buffer B, which is the purified vitellogenin. Finally, wash the high-efficiency anion-exchange membrane with 10 ml of recovery buffer (phosphate or Tris-hydrochloric acid buffer at pH=6.5-8.5, concentration 0.02 mol/L, containing 1 mol/L NaCl), and then use it for the next separation.
在完成本发明的过程中,我们从不同种类的卵生动物:鲤鱼、鲫鱼、鳙鱼、泥鳅和鸡的血清以及斑马鱼的全身匀浆液中成功的提取纯化了相应的卵黄蛋白原,并用高效凝胶过滤色谱和聚丙烯酰胺凝胶变性电泳对所纯化的蛋白进行了鉴定,结果证明蛋白分子量为440-500KD,与文献报道一致。另外,我们还与文献中经常采用的阴离子交换柱色谱方法进行了比较,如下表所示,结果证明本发明可大大节省时间和溶剂用量,并且操作简单。In the process of completing the present invention, we have successfully extracted and purified corresponding vitellogenin from different types of oviparous animals: carp, crucian carp, bighead carp, loach and chicken serum and zebrafish whole body homogenate, and used high-efficiency coagulation Gel filtration chromatography and polyacrylamide gel denaturation electrophoresis were used to identify the purified protein, and the results showed that the molecular weight of the protein was 440-500KD, which was consistent with the literature reports. In addition, we also compared with the anion exchange column chromatography method frequently used in the literature, as shown in the table below, the results prove that the present invention can greatly save time and solvent consumption, and is easy to operate.
表1、本发明与传统阴离子交换柱色谱方法分离卵黄蛋白原的比较Table 1, the comparison of the present invention and traditional anion-exchange column chromatographic method for separating vitellogenin
参数 本发明 阴离子交换柱色谱Parameters The present invention Anion exchange column chromatography
功能基团 二乙基乙二胺或季胺盐 二乙基乙二胺Functional group Diethylethylenediamine or quaternary ammonium salt Diethylethylenediamine
分离时间 5分钟 600分钟Separation time 5 minutes 600 minutes
溶液用量 40毫升 500毫升Amount of solution 40ml 500ml
工作温度 室温 4℃Working Temperature Room Temperature 4℃
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03109189 CN1206240C (en) | 2003-04-07 | 2003-04-07 | High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03109189 CN1206240C (en) | 2003-04-07 | 2003-04-07 | High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1439649A CN1439649A (en) | 2003-09-03 |
| CN1206240C true CN1206240C (en) | 2005-06-15 |
Family
ID=27796717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03109189 Expired - Fee Related CN1206240C (en) | 2003-04-07 | 2003-04-07 | High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1206240C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109111515A (en) * | 2018-09-06 | 2019-01-01 | 大连工业大学 | A kind of method for preparing main yolk protein from sea cucumber coelom |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102067075B1 (en) * | 2011-12-22 | 2020-01-17 | 제넨테크, 인크. | Ion exchange membrane chromatography |
| CN102768282B (en) * | 2012-07-20 | 2014-11-26 | 湖北省农业科学院农产品加工与核农技术研究所 | Preparation and detection methods of kit for detecting chub vitellogenin (VTG) |
-
2003
- 2003-04-07 CN CN 03109189 patent/CN1206240C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109111515A (en) * | 2018-09-06 | 2019-01-01 | 大连工业大学 | A kind of method for preparing main yolk protein from sea cucumber coelom |
| CN109111515B (en) * | 2018-09-06 | 2021-05-14 | 大连工业大学 | A kind of method for preparing main yolk protein from sea cucumber coelom |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1439649A (en) | 2003-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6627737B1 (en) | Factor IX purification methods | |
| CN110540961B (en) | Annexin V-FITC exosome capture affinity magnetic bead, preparation method thereof and method for extracting exosome by using same | |
| CN102977180B (en) | A kind of method of comprehensive utilization of C ohn component I V | |
| RU2453555C2 (en) | Method of purifying apolipoprotein a-1 | |
| Connell et al. | The purification of haptoglobin | |
| JPH01311028A (en) | Purification of hepatic protein | |
| JPS59225196A (en) | Tissue protein and isolation | |
| CN104530207B (en) | A kind of method that soybean agglutinin is isolated and purified from soy-bean whey | |
| TWI226834B (en) | Process for selectively isolating antibody isomers | |
| CN113101737A (en) | Affinity tangential flow filtration system and construction method thereof, and exosome extraction method and application | |
| US4254021A (en) | Tissue specific protein and process for preparing same | |
| LU501670B1 (en) | A Method for as1-Casein Separation | |
| JPWO2009019889A1 (en) | Method for concentrating low molecular weight proteins and peptides in body fluid samples | |
| CN103172724A (en) | Method for extracting ovum macroglobulin from egg white | |
| CN1206240C (en) | High efficiency ionic exchange membrane chromatography decontamination vitelloenin technology | |
| CN101240010A (en) | Method for rapid separation and purification of C-phycocyanin and isophycocyanin from cyanobacteria | |
| CN103505908B (en) | A kind of method utilizing mixed mode chromatography media to be continuously separated antibody purification | |
| CN109879930A (en) | A kind of purification process of recombinant protein | |
| DE3418888A1 (en) | TISSUE PROTEIN PP (DOWN ARROW) 1 (DOWN ARROW) (DOWN ARROW) 8 (DOWN ARROW), METHOD FOR ITS DETERMINATION AND USE | |
| CA1243014A (en) | Tissue protein pp in21 xx, a process for obtaining it and its use | |
| CN101948535B (en) | Method for separating immunoglobulin IgY from chicken blood | |
| WO2019075892A1 (en) | Method for purifying placenta-like chondroitin sulfate a or derivative thereof by affinity chromatography | |
| JPS62259596A (en) | Purification of hybrid protein | |
| CN109608516B (en) | Rapid purification method of royal jelly major proteins 1, 2 and 3 | |
| JP2010148442A (en) | Method for concentrating glycopeptide having sulfated sugar chain and kit therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050615 Termination date: 20130407 |